CD38 and Miyoshi myopathy: The results of experiments conducted by Krejcik et al. on blood samples taken from patients treated with DARA revealed that not only does DARA induce rapid reduction in CD38 on MM cells, it also reduces CD38 levels on NK cells, T cells, and B cells [77].